Thus, ApoE neutralizing antibodies can provide broad protection from infection by continuously emerging SARS‐CoV‐2 variants of concern, overcoming the limitation of antibodies targeting the spike protein for which the encoding gene can be frequently mutated. This evidence concerns the gene APOE and infection.